This summer’s family barbecue was supposed to be a celebration of sorts—coming together for the first time since the pandemic pulled the plug on group activities. But your joy was cut short by an ...

Apogee Therapeutics, Inc. (NASDAQ: APGE) on Tuesday shared interim data from the Phase 1b trial of zumilokibart (APG777) in patients with mild-to-moderate asthma. The data covers 19 adult patients ...

Chinese scientists have developed a groundbreaking cell therapy that could provide long-term relief for asthma patients with just a single shot. This new treatment, which has shown promising results ...

Robust real-world data on the effectiveness of biologic therapies in children with severe asthma remain limited, particularly ...

More than 24 million Americans have been diagnosed with asthma, and 10 percent of them have a tough time controlling it, even with treatment. But a new form of therapy -- known as biologic -- is ...

Tony Cook runs up to 7 miles a day, but until recently, his severe asthma made it too painful for him to work out for very long. “It feels like a coil is just tightening around your lungs and you ...

When an asthma attack occurs, many sufferers use a device — a “spacer” — to increase the chances that rescue medicine travels from an inhaler all the way down to the airways where it is needed. A new ...

JACKSON , MS, UNITED STATES, March 10, 2026 /EINPresswire.com/ -- As the warmer weather of spring approaches, so does ...

Among patients with asthma without diabetes, the risk for exacerbation was decreased with GLP-1 receptor agonist exposure, ...

Current asthma treatments don't work in all patients, and they don't provide long-term relief from potentially deadly asthma attacks. Scientists at La Jolla Institute for Immunology (LJI) are ...

Quick-relief meds, also called rescue or short-acting drugs, are just what they sound like an 11th-hour Hail Mary when an asthma attack kicks in. “Whereas long-term and control medications treat ...